Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation AMARILLO, Texas, Nov. 7, 2017 /PRNewswire/ -- Amazing...

Parks Associates today announced new research showing 41% of U.S. broadband households plan to purchase a smart home product in the next 12 months, including 27% with high purchase intentions. The...

Nektar Therapeutics (Nasdaq: NKTR) today announced that new clinical data will be presented for NKTR-214, Nektar's lead immuno-oncology candidate, a CD122-biased agonist, at the Society for...

Novartis announced today results from the FUTURE 5 study showing Cosentyx® (secukinumab) reduced the signs and symptoms of psoriatic arthritis (PsA) while significantly inhibiting the progression...

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product...

Nektar Therapeutics (Nasdaq: NKTR) today announced it is presenting preclinical data on NKTR-358, a potential first-in-class resolution therapeutic that may address the underlying immune system...

Pique Therapeutics, Inc. today announced positive results for PT 107 from its Phase 2 clinical trial in patients with late-stage, second-line non-small cell lung cancer (NSCLC). These results will...

Elastifile, the enterprise hybrid cloud data management company, today announced that it will be exhibiting its Cross-Cloud Data Fabric at SC17, the international conference for high performance...

Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing entinostat and SNDX-6352 in multiple cancer indications, today...

Champions Oncology, Inc. (Nasdaq: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, will be participating in...